Hunan Caprico Biotechnologies Co., Ltd. announced that it has received tens of millions of yuan in a round of funding from new investors Guangzhou Huangpu Biomedical Fund Management Co., Ltd., and Yabao Pharmaceutical Group Co., Ltd on September 18, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 CNY | +1.23% | +6.67% | -4.93% |
1st Jan change | Capi. | |
---|---|---|
-4.93% | 640M | |
+20.54% | 43.18B | |
+20.67% | 22.59B | |
+15.15% | 14.56B | |
+42.40% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Hunan Caprico Biotechnologies Co., Ltd. announced that it has received funding from Guangzhou Huangpu Biomedical Fund Management Co., Ltd., Yabao Pharmaceutical Group Co., Ltd